Search - tctmd.com

Displaying 1 - 20 of 41

Sort: Relevancy | Date

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

L.A. McKeown

November 17, 2016

Presentation TCT 2016

AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents

Presenter: Ron Waksman, Robert-Jan van Geuns, Michael Haude

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: Platinum Chromium Everolimus-Eluting Stents - Evolution From the Fluoropolymer-Based Promus Element to the Bioabsorbable Polymer-Based Synergy

Presenter: Dean J. Kereiakes, Pieter C. Smits

October 30, 2016

Presentation TCT 2016

The Evolution of Therapies for Coronary Artery Disease and Valve Disorders in My Lifetime

Presenter: A. Pieter Kappetein

October 30, 2016

News Daily News

Interactive Smartphone App Can Motivate MI Patients to Take Their Meds

Caitlin E. Cox

June 06, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

L.A. McKeown

May 24, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Daily News

Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib

Todd Neale

April 21, 2016

News Industry News

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

November 29, 2015

News Daily News

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

L.A. McKeown

November 17, 2015

News Daily News

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

L.A. McKeown

September 09, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Daily News

Meta-analysis Confirms Safety of PCI without Surgical Backup

July 16, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Industry News

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

June 18, 2015

News Daily News

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Caitlin E. Cox

May 29, 2015

News Daily News

EuroPCR 2015 Debate las Intervenciones TAVR, la Optimización de las PCI y Más

Caitlin E. Cox

May 29, 2015

Advertisement

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Stent Design and Comprehensive Data Review: Platinum Chromium Everolimus-Eluting Stents - Evolution From the Fluoropolymer-Based Promus Element to the Bioabsorbable Polymer-Based Synergy

The Evolution of Therapies for Coronary Artery Disease and Valve Disorders in My Lifetime

Interactive Smartphone App Can Motivate MI Patients to Take Their Meds

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Meta-analysis Confirms Safety of PCI without Surgical Backup

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

EuroPCR 2015 Debate las Intervenciones TAVR, la Optimización de las PCI y Más

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content